Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with obsessive-compulsive disorder and major depressive disorder.

Literature DB >> 12658528

Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with obsessive-compulsive disorder and major depressive disorder.

Vladimir Coric, Snezana Milanovic, Suzanne Wasylink, Pinal Patel, Robert Malison, John H Krystal.

Abstract

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2003 PMID： 12658528 DOI： 10.1007/s00213-003-1396-z

Source DB: PubMed Journal: Psychopharmacology (Berl) ISSN： 0033-3158 Impact factor: 4.530

× No keyword cloud information.

7 in total

1. Antidepressant effects of ketamine in depressed patients.

Authors: R M Berman; A Cappiello; A Anand; D A Oren; G R Heninger; D S Charney; J H Krystal
Journal: Biol Psychiatry Date: 2000-02-15 Impact factor: 13.382

2. Differential inhibition by riluzole, lamotrigine, and phenytoin of sodium and calcium currents in cortical neurons: implications for neuroprotective strategies.

Authors: A Stefani; F Spadoni; G Bernardi
Journal: Exp Neurol Date: 1997-09 Impact factor: 5.330

3. Effects of riluzole on electrically evoked neurotransmitter release.

Authors: T Jehle; J Bauer; E Blauth; A Hummel; M Darstein; T M Freiman; T J Feuerstein
Journal: Br J Pharmacol Date: 2000-07 Impact factor: 8.739

Review 4. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments.

Authors: J H Krystal; G Sanacora; H Blumberg; A Anand; D S Charney; G Marek; C N Epperson; A Goddard; G F Mason
Journal: Mol Psychiatry Date: 2002 Impact factor: 15.992

5. Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine.

Authors: D R Rosenberg; F P MacMaster; M S Keshavan; K D Fitzgerald; C M Stewart; G J Moore
Journal: J Am Acad Child Adolesc Psychiatry Date: 2000-09 Impact factor: 8.829

6. Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex.

Authors: G J Marek; R A Wright; D D Schoepp; J A Monn; G K Aghajanian
Journal: J Pharmacol Exp Ther Date: 2000-01 Impact factor: 4.030

7. Riluzole inhibits the persistent sodium current in mammalian CNS neurons.

Authors: A Urbani; O Belluzzi
Journal: Eur J Neurosci Date: 2000-10 Impact factor: 3.386

7 in total

36 in total

1. Topiramate augmentation in a patient with obsessive-compulsive disorder.

Authors: Michael Van Ameringen; Beth Patterson
Journal: J Psychiatry Neurosci Date: 2015-09 Impact factor: 6.186

2. Glutamate system genes associated with ventral prefrontal and thalamic volume in pediatric obsessive-compulsive disorder.

Authors: Paul Daniel Arnold; Frank P Macmaster; Gregory L Hanna; Margaret A Richter; Tricia Sicard; Eliza Burroughs; Yousha Mirza; Phillip C Easter; Michelle Rose; James L Kennedy; David R Rosenberg
Journal: Brain Imaging Behav Date: 2009-03-01 Impact factor: 3.978

3. N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder.

Authors: Daniel L Lafleur; Christopher Pittenger; Ben Kelmendi; Tom Gardner; Suzanne Wasylink; Robert T Malison; Gerard Sanacora; John H Krystal; Vladimir Coric
Journal: Psychopharmacology (Berl) Date: 2005-12-22 Impact factor: 4.530

4. Glutamate and the Treatment of Obsessive-Compulsive Disorder.

Authors: Frank P Macmaster; David R Rosenberg
Journal: Psychopharm Rev Date: 2010-05-01

5. Riluzole in the prelimbic medial prefrontal cortex attenuates veratrine-induced anxiety-like behaviors in mice.

Authors: Masanori Ohashi; Akiyoshi Saitoh; Misa Yamada; Jun-Ichiro Oka; Mitsuhiko Yamada
Journal: Psychopharmacology (Berl) Date: 2014-08-17 Impact factor: 4.530

6. Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: a preliminary study.

Authors: Paul D Arnold; David R Rosenberg; Emanuela Mundo; Subi Tharmalingam; James L Kennedy; Margaret A Richter
Journal: Psychopharmacology (Berl) Date: 2004-04-09 Impact factor: 4.530